UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Aufbereitung industrieller Schlacken mittels mobiler Aufbereitungsaggregate von THE STANDARD

BHM. Berg- und hüttenmännische Monatshefte, 2013, Vol.158 (6), p.219-225

Klade, Michael

2013

Link zum Volltext

Verfügbarkeit prüfen

Entwicklung der Gebirgsmechanik bei den alpinen Salzbergbauen der Salinen Austria AG

BHM. Berg- und hüttenmännische Monatshefte, 2010-08, Vol.155 (8), p.365-371

2010

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41

Gastroenterology (New York, N.Y. 1943), 2008-05, Vol.134 (5), p.1385-1395.e1

2008

Link zum Volltext

Verfügbarkeit prüfen

Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses

Journal of virology, 2015-08, Vol.89 (16), p.8304-8317

2015

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects

Vaccine, 2006-05, Vol.24 (20), p.4343-4353

2006

Link zum Volltext

Verfügbarkeit prüfen

Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination

Vaccine, 2012-04, Vol.30 (19), p.2943-2950

2012

Link zum Volltext

Verfügbarkeit prüfen

Germline genetic factors influence the outcome of interferon-α therapy in polycythemia vera

Blood, 2021-01, Vol.137 (3), p.387-391

2021

Link zum Volltext

Verfügbarkeit prüfen

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO® , IC51

Vaccine, 2011-03, Vol.29 (14), p.2607-2612

2011

Link zum Volltext

Verfügbarkeit prüfen

Germline Genetic Factors Affecting Interferon Alpha Therapy in Polycythemia Vera

Blood, 2019-11, Vol.134 (Supplement_1), p.1685-1685

2019

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C

Vaccine, 2009-08, Vol.27 (37), p.5142-5151

2009

Link zum Volltext

Verfügbarkeit prüfen

Monitoring Molecular Response, Minimal Residual Disease and Clonal Structures in Polycythemia Vera Patients Treated with Interferon Alpha

Blood, 2016-12, Vol.128 (22), p.1944-1944

2016

Link zum Volltext

Verfügbarkeit prüfen

Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients

Vaccine, 2007-09, Vol.25 (37), p.6793-6806

2007

Link zum Volltext

Verfügbarkeit prüfen

Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response

Virology journal, 2007-06, Vol.4 (1), p.58-58, Article 58

2007

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals

Biological chemistry, 2008-05, Vol.389 (5), p.551-559

2008

Link zum Volltext

Verfügbarkeit prüfen

Translational regulator RpL10p/Grc5p interacts physically and functionally with Sed1p, a dynamic component of the yeast cell surface

Yeast (Chichester, England), 2003-03, Vol.20 (4), p.281-294

2003

Link zum Volltext

Verfügbarkeit prüfen

GRC5 and NMD3 function in translational control of gene expression and interact genetically

Current genetics, 1999-01, Vol.34 (6), p.419-429

1999

Link zum Volltext

Verfügbarkeit prüfen

yeast growth control gene GRC5 is highly homologous to the mammalian putative tumor suppressor gene QM

Yeast (Chichester, England), 1996, Vol.12 (1), p.53-65

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(28)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Humans
(13)
Adult
(7)
Hepatitis C Virus
(6)
Male
(6)
Medicine, Research & Experimental
(6)
Microbiology
(6)
Middle Aged
(6)
Research & Experimental Medicine
(6)
Virology
(6)
Female
(5)
Immunology
(5)
Treatment Outcome
(5)
Adolescent
(4)
Allergy And Immunology
(4)
Applied Microbiology
(4)
Biological And Medical Sciences
(4)
Cd8-Positive T-Lymphocytes - Immunology
(4)
Fundamental And Applied Biological Sciences. Psychology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aufbereitung industrieller Schlacken mittels mobiler Aufbereitungsaggregate von THE STANDARD

Entwicklung der Gebirgsmechanik bei den alpinen Salzbergbauen der Salinen Austria AG

Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41

Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses

Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects

Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination

Germline genetic factors influence the outcome of interferon-α therapy in polycythemia vera

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO® , IC51

Germline Genetic Factors Affecting Interferon Alpha Therapy in Polycythemia Vera

Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial

Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C

Monitoring Molecular Response, Minimal Residual Disease and Clonal Structures in Polycythemia Vera Patients Treated with Interferon Alpha

Long-Term Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Polycythemia Vera — Final Phase I/II Peginvera Study Results

Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients

Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response

Switch from Every Two Weeks to Every Four Weeks Administration Schedule of AOP2014, an Innovative Pegylated Interferon Alpha, in Polycythemia Very Patients Allows Maintaining of Efficacy with Improved Toxicity Profile in Phase I/II Study

Four Weeks Administration Schedule of Ropeginterferon Alfa-2b (AOP2014/P1101) in Polycythemia Very Patients Allows Maintaining of Efficacy with Favorable Toxicity Profile in the Phase I/II Peginvera Stud

Long Term Efficacy and Safety Results and Analysis of Dose Correlations from the Phase I/II Peginvera Study of Ropeginterferon Alfa-2b, a Novel IFNa-2b, in Polycythemia Vera Patient

Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals

Efficacy and Safety Of AOP2014/P1101, a Novel, Investigational Mono-Pegylated Proline-Interferon Alpha-2b, In Patients With Polycythemia Vera (PV): Update On 51 Patients From The Ongoing Phase I/II Peginvera Study

AOP2014, a Novel Peg-Proline-Interferon Alpha-2b with Improved Pharmacokinetic Properties, Is Safe and Well Tolerated and Shows Promising Efficacy in Patients with Polycythemia Vera (PV)

Translational regulator RpL10p/Grc5p interacts physically and functionally with Sed1p, a dynamic component of the yeast cell surface

GRC5 and NMD3 function in translational control of gene expression and interact genetically

yeast growth control gene GRC5 is highly homologous to the mammalian putative tumor suppressor gene QM

Zurück auf Los oder Neustart?: Tourismus, Kirchen und Nachhaltigkeit

Suchergebnisse filtern